Biomarker-Driven Drug Development in Dermatology
Time: 11:30 am
day: Day One
Details:
• How leveraging and integrating methodologies, including RNA sequencing and multiomics approaches can verify drug pharmacodynamics, demonstrating efficacy and safety through biomarkers
• Investigator-initiated studies with approved drugs to validate novel endpoints
• Deep-phenotyping of patients with inflammatory skin diseases for stratification and improved disease understanding
• Case study with anti-IL-23 therapy for psoriasis, presenting recent outcomes using a technology driven approach
